Reported Sunday, Natera Will Unveil SAGITTARIUS Phase III Data At ESMO 2026 Showing Signatera Results Changed Treatment Plans For One In Three Colon Cancer Patients, Of Which 87% De-Escalated On MRD Negativity

뉴스 본문을 불러오고 있어요.

Reported Sunday, Natera Will Unveil SAGITTARIUS Phase III Data At ESMO 2026 Showing Signatera Results Changed Treatment Plans For One In Three Colon Cancer Patients, Of Which 87% De-Escalated On MRD Negativity | 웨이프 WAPE

Reported Sunday, Natera Will Unveil SAGITTARIUS Phase III Data At ESMO 2026 Showing Signatera Results Changed Treatment Plans For One In Three Colon Cancer Patients, Of Which 87% De-Escalated On MRD Negativity

기사 요약

관련 종목

댓글 —